← Back to Clinical Trials
Recruiting NCT00616317
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Trial Parameters
Condition Antiphospholipid Syndrome
Sponsor University of California, Davis
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 1 Minute
Max Age 18 Years
Start Date 2006-09
Completion 2040-01
Brief Summary
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or younger at the onset of disease * Presence of Vascular Thrombosis * UC Davis patient * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma Exclusion Criteria: * Infants born to mothers with APS * Infants with congenital thrombophilia